Biohaven BHVN
NYSE BHVN
$15.21 +0.10 (+0.66%)
At close: Nov 11, 2026 · 4:00 PM EST

Biohaven (BHVN) Other Accumulated Expenses (2022 - 2023)

Updated

Analysis

Biohaven (BHVN) Other Accumulated Expenses (2022 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Biohaven 2.28 Bn 1.18 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 28,000.00
Jun 30, 2023 40.42 Mn
Mar 31, 2023 61.55 Mn
Dec 31, 2022 35.21 Mn
API Access

Biohaven Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BHVN&period=max&api_key=YOUR_API_KEY